{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:39:50Z","timestamp":1787071190143,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>Psoriasis is a multifactorial, chronic, immune-mediated inflammatory condition. Psoriasis often goes beyond the skin, nails and scalp and involves the eyes (uveitis), joints (arthritis) and several metabolic derangements, as seen in various studies. It is strongly associated with features of the metabolic syndrome (MetS) like hypertension, obesity, dyslipidaemia, type 2 diabetes, insulin resistance and non-alcoholic fatty liver disease. Amongst various skin diseases, MetS has the strongest association with psoriasis. The risk of having MetS is almost doubled in patients with psoriasis as compared to healthy individuals. Both conditions share a common pathophysiological background in terms of genetics, inflammatory markers, lifestyle choices, etc. The association of psoriasis with MetS is clinically important as it influences the prognosis, quality of life and choice of treatment. Systemic conventional drugs should be used with caution in such patients, as their long-term use may contribute to metabolic impairment. The treating dermatologist should be aware of such associations and their implications, and a more holistic approach should be taken to manage psoriasis where equal importance is given to lifestyle and dietary modifications and comorbid conditions, in addition to the pharmacological therapy so as to decrease the burden of the disease for both the patient and the health system.<\/jats:p>","DOI":"10.4103\/ijd.ijd_418_23","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T16:38:35Z","timestamp":1724949515000},"page":"274-277","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Psoriasis and its Association with Metabolic Syndrome"],"prefix":"10.4103","volume":"68","author":[{"given":"Komal","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Grant Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"De","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250921","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/abd1806-4841.20175178","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based cross-sectional study","volume":"92","author":"Mil\u010di\u0107","year":"2017","journal-title":"An Bras Dermatol"},{"key":"R2-20250921","first-page":"e6369","article-title":"Psoriasis and metabolic syndrome: Comorbidities and environmental and therapeutic implications","volume":"11","author":"Peralta","year":"2019","journal-title":"Cureus"},{"key":"R3-20250921","first-page":"1","article-title":"Metabolic syndrome \u2013 the underbelly of dermatology","volume":"26","author":"Agarwal","year":"2019","journal-title":"Gulf J Dermatol Venerol"},{"key":"R4-20250921","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/ijd.IJD_321_20","article-title":"Metabolic status, obesity, and quality of life in patients with acne vulgaris: A cross-sectional case-control study","volume":"66","author":"Podder","year":"2021","journal-title":"Indian J Dermatol"},{"key":"R5-20250921","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13098-018-0311-z","article-title":"Metabolic syndrome and the skin: A more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients","volume":"10","author":"Stefanadi","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"R6-20250921","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"R7-20250921","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0019-5154.113950","article-title":"Metabolic syndrome and skin: Psoriasis and beyond","volume":"58","author":"Pandhi","year":"2013","journal-title":"Indian J Dermatol"},{"key":"R8-20250921","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin Dermatol"},{"key":"R9-20250921","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/hr.2010.32","article-title":"Seasonal variation in metabolic syndrome prevalence","volume":"33","author":"Kamezaki","year":"2010","journal-title":"Hypertens Res"},{"key":"R10-20250921","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/BOR.0b013e3283031c99","article-title":"Psoriasis and metabolic disease: Epidemiology and pathophysiology","volume":"20","author":"Azfar","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"R11-20250921","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mehy.2008.06.049","article-title":"The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1","volume":"72","author":"Cabrijan","year":"2009","journal-title":"Med Hypotheses"},{"key":"R12-20250921","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ced.13014","article-title":"Psoriasis and metabolic syndrome in children: Current data","volume":"42","author":"Pietrzak","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"R13-20250921","first-page":"1","article-title":"Management of moderate to severe psoriasis in patients with metabolic comorbidities","volume":"2","author":"Gisondi","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"R14-20250921","doi-asserted-by":"crossref","first-page":"e12812","DOI":"10.1111\/dth.12812","article-title":"Metabolic syndrome in dermatology: Treatment and management for dermatologists","volume":"32","author":"Engin","year":"2019","journal-title":"Dermatol Ther"},{"key":"R15-20250921","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/idoj.IDOJ_437_18","article-title":"Apremilast in psoriasis and beyond: Big hopes on a small molecule","volume":"10","author":"Afra","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"R16-20250921","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon","year":"2011","journal-title":"JAMA"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_418_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:51Z","timestamp":1787067771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_418_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_418_23","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}